Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
P/S ratio for Viridian Therapeutics (VRDN)
P/S ratio as of May 2024 (TTM): > 1000
According to Viridian Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2973.64. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Viridian Therapeutics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 449.77% |
| 2022 | 663 | 315.63% |
| 2021 | 160 | 140.81% |
| 2020 | 66.3 | 1667.52% |
| 2019 | 3.75 | -66.34% |
| 2018 | 11.1 | -80.83% |
| 2017 | 58.1 | 5121.13% |
| 2016 | 1.11 | -64.47% |
| 2015 | 3.13 | 40.9% |
| 2014 | 2.22 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |